ALLR
Income statement / Annual
Last year (2023), Allarity Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Allarity Therapeutics, Inc.'s net income was -$11.90 M.
See Allarity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$120,000.00
|
| Cost of Revenue |
$37,000.00 |
$120,000.00 |
$106,000.00 |
$86,000.00 |
$0.00 |
| Gross Profit |
-$37,000.00 |
-$120,000.00 |
-$106,000.00 |
-$86,000.00 |
$120,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
1 |
| Research and Development
Expenses |
$7.87 M
|
$6.93 M
|
$14.20 M
|
$5.13 M
|
$6.37 M
|
| General & Administrative
Expenses |
$10.03 M
|
$9.96 M
|
$12.36 M
|
$4.10 M
|
$3.87 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$10.03 M
|
$9.96 M
|
$12.36 M
|
$4.10 M
|
$3.87 M
|
| Other Expenses |
$0.00 |
$0.00 |
-$474,000.00 |
-$681,000.00 |
$0.00 |
| Operating Expenses |
$17.89 M |
$16.89 M |
$26.56 M |
$9.23 M |
$10.24 M |
| Cost And Expenses |
$17.93 M |
$16.89 M |
$26.56 M |
$9.23 M |
$10.24 M |
| Interest Income |
$22,000.00 |
$30,000.00 |
$0.00 |
$0.00 |
$7,000.00 |
| Interest Expense |
$498,000.00 |
$223,000.00 |
$499,000.00 |
$227,000.00 |
$3.31 M |
| Depreciation &
Amortization |
$37,000.00
|
$120,000.00
|
$106,000.00
|
$86,000.00
|
$85,000.00
|
| EBITDA |
-$12.08 M
|
-$17.24 M
|
-$25.91 M
|
-$6.01 M
|
-$15.58 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
-83.83 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
-146.76
|
| Total Other
Income/Expenses Net |
$5.31 M
|
-$687,000.00
|
$41,000.00
|
$1.90 M
|
-$8.86 M
|
| Income Before Tax |
-$12.62 M |
-$17.58 M |
-$26.52 M |
-$7.23 M |
-$18.98 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
-158.14
|
| Income Tax Expense |
-$717,000.00 |
-$1.52 M |
$133,000.00 |
-$2.16 M |
-$4.58 M |
| Net Income |
-$11.90 M |
-$16.06 M |
-$26.65 M |
-$5.07 M |
-$14.40 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
-120 |
| EPS |
-0.0103 |
-1856055 |
-3520104 |
-1698639 |
-189613 |
| EPS Diluted |
-0.0103 |
-1856055 |
-3520104 |
-1698639 |
-189613 |
| Weighted Average Shares
Out |
$1.99 B
|
$11.34
|
$7.57
|
$3.89
|
$3.89
|
| Weighted Average Shares
Out Diluted |
$1.99 B
|
$11.34
|
$7.57
|
$3.89
|
$3.89
|
| Link |
|
|
|
|
|
